Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 72-year-old woman is brought to the emergency department by her daughter due to a 2-day history of persistent nausea, vomiting, and profound generalized weakness. The patient also reports seeing "yellow halos" around lights in her home. Her medical history includes heart failure with reduced ejection fraction, atrial fibrillation, and hypertension. Her daily medications are digoxin, furosemide, lisinopril, and rivaroxaban. Vital signs show a heart rate of 48/min and blood pressure of 105/65 mm Hg. Physical examination reveals a lethargic woman with dry mucous membranes.

Laboratory studies reveal:
TestResult
Sodium134 mEq/L
Potassium3.0 mEq/L
Chloride98 mEq/L
Bicarbonate26 mEq/L
Blood urea nitrogen42 mg/dL
Creatinine1.9 mg/dL (baseline 1.1 mg/dL)

Which of the following are appropriate next steps in the evaluation and management of this patient? (Select all that apply)

  1. Obtain a 12-lead electrocardiogramCevap
  2. Measure serum digoxin concentrationCevap
  3. C
    Administer intravenous calcium gluconate
  4. D
    Order a non-contrast CT scan of the head
  5. E
    Withhold potassium supplementation due to the elevated serum creatinine

Cevap

The appropriate next steps are to obtain a 12-lead electrocardiogram and measure the serum digoxin concentration.
The patient's presentation of nausea, vomiting, lethargy, visual changes ('yellow halos'), and significant bradycardia is highly suspicious for digoxin toxicity. This toxicity is likely precipitated by acute kidney injury (which reduces digoxin clearance) and concurrent hypokalemia from furosemide use (which increases myocardial sensitivity to digoxin). The most critical initial steps in evaluating and monitoring this patient are to obtain a serum digoxin concentration to definitively confirm the diagnosis, and a 12-lead electrocardiogram to evaluate for potentially life-threatening arrhythmias (such as advanced atrioventricular block or ventricular tachycardia). Additionally, potassium should be carefully but promptly repleted, as hypokalemia exacerbates the toxicity.

Adım Adım Çözüm

1
Identify the primary clinical syndrome
The patient presents with gastrointestinal symptoms, specific visual disturbances ('yellow halos'), and bradycardia in the setting of digoxin use.
These findings represent the classic presentation of acute-on-chronic digoxin toxicity.
2
Analyze contributing laboratory factors
The patient has hypokalemia (3.0 mEq/L) and acute kidney injury (creatinine 1.9 mg/dL).
Acute kidney injury decreases digoxin renal clearance, leading to accumulation. Hypokalemia increases digoxin binding to the Na+/K+-ATPase pump, severely exacerbating its toxic effects.
3
Determine immediate monitoring and management steps
Order a 12-lead ECG and a serum digoxin level.
An ECG is mandatory to assess for life-threatening arrhythmias (such as atrioventricular block or ventricular arrhythmias). Serum levels confirm the diagnosis and help determine if digoxin-specific antibody fragments are indicated.

Anahtar Kavram

The initial evaluation and monitoring of digoxin toxicity involves confirming serum levels, assessing for arrhythmias with an electrocardiogram, and aggressively correcting exacerbating electrolyte abnormalities such as hypokalemia.
Tahmini Süre:1m 30s
Bu soruyu puanla